University of British Columbia
Kelowna, British Columbia, V1V 1V7, Canada
NCT Number: NCT02860728
Structural changes in skeletal muscles of patients with chronic obstructive pulmonary disease (COPD) have been linked to impaired muscle function, reduced exercise capacity, and increased mortality associated with this disease. Muscle dysfunction also contributes to dyspnea intensity and the ability to sustain exercise, making aerobic exercise training intolerable at the intensity and/or volume required to achieve clinically important changes. Resistance training (RT) is an attractive exercise modality because it is efficacious and more tolerable initially. No work has examined whether a short-term RT program can reduce exertional symptoms and improve exercise tolerance (dyspnea and leg fatigue) in patients with COPD.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Kelowna, British Columbia, V1V 1V7, Canada
Skeletal muscle dysfunction is common in patients with COPD and has been recognized as a contributing factor to reduced exercise capacity, health related quality of life and increased mortality associated with this disease. Several structural changes in the limb muscles of patients have previously been reported and have been linked to the known reductions in muscle strength and endurance commonly reported in COPD. Muscle dysfunction, lower extremity muscle strength, and muscle fatigue also contribute to the intensity of dyspnea and the ability to sustain exercise mostly through stimulation of type III and IV muscle afferents. As such, many patients who primarily perform aerobic exercise training as part of pulmonary rehabilitation are unable to tolerate the intensity and/or volume of exercise required to achieve clinically important changes in exercise capacity or symptom relief. Resistance training (RT) is an attractive exercise modality for patients with COPD because it is efficacious and often more tolerable initially. To our knowledge no one has examined whether similar benefits to those elicited by longer RT programs can be attained in just 4 weeks using multi-joint, multi-muscle exercises and individualized progression. If a short term RT program can improve muscle quality, enhance endurance, and reduce type III and IV afferent activity then it would reduce the drive to breathe and thus dyspnea. These adaptations would likely translate into improved exercise tolerance making it feasible to "pre-habilitate" COPD patients with tolerable RT, allowing them to achieve a higher volume/intensity of endurance training, thus making pulmonary rehabilitation more effective.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lower body resistance exercises will be prescribed in various combinations over multiple days and individually modified and progressed to achieve advances in both movement pattern, intensity, and exercise volume.
Time frame: Baseline and post 4 weeks (12 sessions) of resistance training
The change in the sensory intensity of dyspnea measured at an iso-time during the constant load exercise trials post RT
Time frame: Baseline and post 4 weeks (12 sessions) of resistance training
The change in the time to exhaustion during constant load exercise on a stationary cycle ergometer.
Time frame: Baseline and post 4 weeks (12 sessions) of resistance training
The change in the unpleasantness and sensory qualities of dyspnea measured at an iso-time during the constant load exercise trials post RT
Time frame: Baseline and post 4 weeks (12 sessions) of resistance training
Change in the amount of decline in force production after 3 minutes of electrical stimulation of femoral nerve at 25% of maximal voluntary contraction
Time frame: Baseline and post 4 weeks (12 sessions) of resistance training
The change in 6RM quadriceps muscle strength and quadricep muscle endurance at 50% of predicted 1 RM
University of British Columbia
Other
A Novel Individualized Resistance Training Program to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05997550
Chronic Disease, Chronic Obstructive Pulmonary Disease
Ankara, Çamlıca Mahallesi, Turkey (Türkiye)
View Trial DetailsNCT05506202
Chronic Disease, Chronic Obstructive Pulmonary Disease
Hong Kong
View Trial DetailsNCT04459143
Chronic Disease, Chronic Obstructive Pulmonary Disease
Aincourt, France
View Trial DetailsNCT04709562
Acid-Base Imbalance, Acidosis
Los Angeles, California, United States
View Trial Details